Does ENALAPRIL Cause Ventricular hypertrophy? 9 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 9 reports of Ventricular hypertrophy have been filed in association with ENALAPRIL (Enalapril maleate oral solution). This represents 0.1% of all adverse event reports for ENALAPRIL.
9
Reports of Ventricular hypertrophy with ENALAPRIL
0.1%
of all ENALAPRIL reports
0
Deaths
2
Hospitalizations
How Dangerous Is Ventricular hypertrophy From ENALAPRIL?
Of the 9 reports, 2 (22.2%) required hospitalization.
Is Ventricular hypertrophy Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ENALAPRIL. However, 9 reports have been filed with the FAERS database.
What Other Side Effects Does ENALAPRIL Cause?
Acute kidney injury (916)
Drug ineffective (599)
Hypotension (556)
Dyspnoea (514)
Hypertension (451)
Hyperkalaemia (448)
Drug interaction (441)
Angioedema (412)
Off label use (347)
Diarrhoea (342)
What Other Drugs Cause Ventricular hypertrophy?
AMLODIPINE (46)
PREDNISONE (37)
PANTOPRAZOLE (36)
ASPIRIN (32)
VALSARTAN (29)
CLOZAPINE (28)
ACETAMINOPHEN (27)
TIOTROPIUM (24)
ALBUTEROL (21)
ONDANSETRON (21)
Which ENALAPRIL Alternatives Have Lower Ventricular hypertrophy Risk?
ENALAPRIL vs ENALAPRIL\HYDROCHLOROTHIAZIDE
ENALAPRIL vs ENALAPRIL\LERCANIDIPINE
ENALAPRIL vs ENASIDENIB
ENALAPRIL vs ENBREL
ENALAPRIL vs ENCORAFENIB